Zobrazeno 1 - 10
of 11
pro vyhledávání: '"René Reitermaier"'
Autor:
René Reitermaier, Michael Skoll, Veronique Touzeau-Roemer, Maximilian C. Aichelburg, Adelheid Elbe-Bürger, Wolfgang Bauer, Armin Rieger, Christopher Schuster
Publikováno v:
Acta Dermato-Venereologica, Vol 101, Iss 11 (2021)
Abstract is missing (Short communication)
Externí odkaz:
https://doaj.org/article/7948e4b3375e4327a4b058548b92634f
Autor:
Friedrich Erhart, Johanna Buchroithner, René Reitermaier, Katrin Fischhuber, Simone Klingenbrunner, Ido Sloma, Dror Hibsh, Renana Kozol, Sol Efroni, Gerda Ricken, Adelheid Wöhrer, Christine Haberler, Johannes Hainfellner, Günther Krumpl, Thomas Felzmann, Alexander M. Dohnal, Christine Marosi, Carmen Visus
Publikováno v:
Acta Neuropathologica Communications, Vol 6, Iss 1, Pp 1-14 (2018)
Abstract Audencel is a dendritic cell (DC)-based cellular cancer immunotherapy against glioblastoma multiforme (GBM). It is characterized by loading of DCs with autologous whole tumor lysate and in vitro maturation via “danger signals”. The recen
Externí odkaz:
https://doaj.org/article/31567993947f492daafe23f1e64695ff
Autor:
Christian Fiala, Adelheid Elbe-Bürger, Julia Staller, René Reitermaier, Nikolaus Fortelny, Pablo A. Vieyra-Garcia, Christof Worda, Clement Staud, Philip Kienzl, Wolfgang Eppel, Tanya Ayub, Anke Scharrer, Thomas Krausgruber
Publikováno v:
Development (Cambridge, England)
article-version (VoR) Version of Record
article-version (VoR) Version of Record
The adult human skin contains a vast number of T cells that are essential for skin homeostasis and pathogen defense. T cells are first observed in the skin at the early stages of gestation; however, our understanding of their contribution to early im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74a8b94e4883f82722c3d023ed925a5d
https://doi.org/10.1242/dev.199781
https://doi.org/10.1242/dev.199781
Autor:
Katrin Fischhuber, Daniela Lötsch, Walter Berger, Alexander M. Dohnal, Fernando J. Sialana, Gert Lubec, Bernadette Blauensteiner, Friedrich Erhart, Simone Klingenbrunner, Thomas Felzmann, Angela Halfmann, Tamara Weiss, René Reitermaier, Carmen Visus, Sabine Spiegl-Kreinecker
Publikováno v:
Cytotherapy. 21:643-658
Background Glioblastoma is the most aggressive type of brain cancer. Dendritic cell (DC)-based immunotherapy against glioblastoma depends on the effectiveness of loaded antigens. Sphere-inducing culture conditions are being studied by many as a poten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7343f770679039ff71b69407e6bd8494
https://doi.org/10.1016/j.jcyt.2019.03.002
https://doi.org/10.1016/j.jcyt.2019.03.002
Autor:
Anke Scharrer, Marita Kölz, Wolfgang Weninger, Adelheid Elbe-Bürger, Thomas Krausgruber, René Reitermaier, Christoph Bock, Manuela Hiess, Pablo A. Vieyra-Garcia, Peter Wolf, Martin Vierhapper, Nikolaus Fortelny, Christof Worda, Christopher Schuster, Wolfgang Eppel, Tanya Ayub, Christian Fiala, Philip Kienzl, Andreas Spittler
Publikováno v:
The Journal of Experimental Medicine
By characterizing the poorly defined T cell composition in developing human fetal skin, Reitermaier et al. identify a unique population of TCR αβγδ+ T cells. These cells may contribute to early skin development and immune defense against invading
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c744cbee5f6e4157222a434dfcb6ef22
http://europepmc.org/articles/PMC7876551
http://europepmc.org/articles/PMC7876551
Autor:
Friedrich Erhart, Simone Klingenbrunner, Hannes Hahne, Adelheid Wöhrer, Sabine Spiegl-Kreinecker, Johanna Buchroithner, Walter Berger, Matthias Hackl, Gerda Ricken, René Reitermaier, Carmen Visus, Katrin Fischhuber, Daniela Lötsch, Christine Marosi, Chen Meng, Johannes A. Hainfellner, Georg Widhalm, Thomas Felzmann, Alexander M. Dohnal, Bernhard Kuster, Susanna Skalicky
Publikováno v:
NPJ Vaccines
npj Vaccines, Vol 5, Iss 1, Pp 1-13 (2020)
npj Vaccines, Vol 5, Iss 1, Pp 1-13 (2020)
Glioblastoma is the most prevalent and aggressive brain cancer. With a median overall survival of ~15–20 months under standard therapy, novel treatment approaches are desperately needed. A recent phase II clinical trial with a personalized immunoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e31131c0d18ca78879a5b30987cb2ca
https://doi.org/10.1038/s41541-019-0149-x
https://doi.org/10.1038/s41541-019-0149-x
Autor:
Bernadette Blauensteiner, Dieter Printz, Katrin Fischhuber, René Reitermaier, Carmen Visus, Friedrich Erhart, Gabriel Zirkovits, Klara Soukup, Daniela Lötsch, Simone Klingenbrunner, Walter Berger, Sabine Spiegl-Kreinecker, Angela Halfmann, Alexander M. Dohnal
Publikováno v:
Journal of Cellular and Molecular Medicine
Glioblastoma is the most dangerous brain cancer. One reason for glioblastoma's aggressiveness are glioblastoma stem‐like cells. To target them, a number of markers have been proposed (CD133, CD44, CD15, A2B5, CD36, CXCR4, IL6R, L1CAM, and ITGA6). A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e79459a6a6939af3efcfcd4ce547a0d5
http://europepmc.org/articles/PMC6307809
http://europepmc.org/articles/PMC6307809
Autor:
Armin Rieger, Wolfgang Bauer, Christopher Schuster, Michael Skoll, Veronique Touzeau-Roemer, Adelheid Elbe-Bürger, René Reitermaier, Maximilian C. Aichelburg
Publikováno v:
Acta Dermato-Venereologica, Vol 101, Iss 11 (2021)
is missing (Short communication)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bd73246e9c991a2c9b1b8b542b617dc
https://doi.org/10.2340/actadv.v101.440
https://doi.org/10.2340/actadv.v101.440
Autor:
Sol Efroni, Johannes A. Hainfellner, Alexander M. Dohnal, Adelheid Wöhrer, Christine Marosi, Thomas Felzmann, René Reitermaier, Friedrich Erhart, Carmen Visus, Simone Klingenbrunner, Katrin Fischhuber, Gerda Ricken, Christine Haberler, Dror Hibsh, Renana Kozol, Günther Krumpl, Johanna Buchroithner, Ido Sloma
Publikováno v:
Acta Neuropathologica Communications
Acta Neuropathologica Communications, Vol 6, Iss 1, Pp 1-14 (2018)
Acta Neuropathologica Communications, Vol 6, Iss 1, Pp 1-14 (2018)
Audencel is a dendritic cell (DC)-based cellular cancer immunotherapy against glioblastoma multiforme (GBM). It is characterized by loading of DCs with autologous whole tumor lysate and in vitro maturation via “danger signals”. The recent phase I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08c0be8c51ce9ed5994187058ee336a2
http://europepmc.org/articles/PMC6280511
http://europepmc.org/articles/PMC6280511
